Corruption and Influence in the Pharmaceutical-Medical Nexus

Major pharmaceutical companies have long wielded influence over doctors globally, shaping trust in the medical profession. Corruption permeates both realms, akin to political circles. With the right incentives, practitioners can be swayed, and their compliance ensured through the specter of license revocation. Even health ministers, ostensibly guardians of public well-being, aren't immune, often entangled in the web of pharmaceutical largesse.

This isn't mere conjecture; my family's roots in the pharmaceutical industry have granted me firsthand insight into its inner workings. Over the years, bribery tactics have evolved. Today, instead of overt payments, doctors are wooed with lavish global conferences, often doubling as luxury retreats. Attendance is optional; loyalty is mandatory. The price? Prescribing costly medications, often unnecessary and rife with adverse effects, exacerbates patients' conditions.

Within the medical fraternity, a culture of protection akin to the Mafia shields errant practitioners. Convictions for malpractice are rare, shielded by the shield of "medical opinion," a seemingly infallible defense, even in the face of patient harm or death. It's a troubling reality where medical judgment supersedes accountability, leaving patients vulnerable and justice elusive.